1. EDRONAX 4 mg tablete

EDRONAX 4 mg tablete

Reboksetin

Composition and organoleptic properties

NameRoleStrengthStrength expression
reboksetin—4 mg/1 tableta—
Organoleptic description—

Drug status

Trigonik (relative driving prohibition).
Permanent cessation of marketing of the medicinal product.

Last drug update date:9. 7. 2026
TEST APPLICATION